MA22866A1 - Procede pour la preparation des composes pour le traitement des troubles neuro-degeneratifs . - Google Patents

Procede pour la preparation des composes pour le traitement des troubles neuro-degeneratifs .

Info

Publication number: MA22866A1
Authority: MA; Morocco
Prior art keywords: treatment; neuro; compounds; preparation; degenerative disorders
Prior art date: 1992-04-03

Application number

MA23157A

Other languages

English (en)

Inventor

Conrad Griffith Ronald

Balestra Michael

John Murray Robert

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-04-03

Filing date

1993-04-02

Publication date

1993-12-31

1992-04-03 Priority claimed from GB929207339A external-priority patent/GB9207339D0/en

1992-04-15 Priority claimed from GB929208290A external-priority patent/GB9208290D0/en

1993-04-02 Application filed by Astra Ab filed Critical Astra Ab

1993-12-31 Publication of MA22866A1 publication Critical patent/MA22866A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Neurology (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

MA23157A 1992-04-03 1993-04-02 Procede pour la preparation des composes pour le traitement des troubles neuro-degeneratifs . MA22866A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB929207339A GB9207339D0 (en)	1992-04-03	1992-04-03	Pharmaceutical compound
GB929208290A GB9208290D0 (en)	1992-04-15	1992-04-15	Pharmaceutical compound having neuroprotective properties

Publications (1)

Publication Number	Publication Date
MA22866A1 true MA22866A1 (fr)	1993-12-31

Family

ID=26300643

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA23157A MA22866A1 (fr)	1992-04-03	1993-04-02	Procede pour la preparation des composes pour le traitement des troubles neuro-degeneratifs .

Country Status (28)

Country	Link
EP (1)	EP0633879B1 (fr)
JP (2)	JP3120810B2 (fr)
KR (1)	KR100259567B1 (fr)
CN (1)	CN1044367C (fr)
AT (1)	ATE163925T1 (fr)
AU (2)	AU3897693A (fr)
CA (1)	CA2133427C (fr)
CZ (1)	CZ288519B6 (fr)
DE (1)	DE69317411T2 (fr)
DK (1)	DK0633879T3 (fr)
DZ (1)	DZ1677A1 (fr)
ES (1)	ES2115055T3 (fr)
FI (1)	FI105025B (fr)
HU (1)	HU211529A9 (fr)
IL (1)	IL105276A (fr)
MA (1)	MA22866A1 (fr)
MX (1)	MX9301935A (fr)
MY (1)	MY110149A (fr)
NO (1)	NO302170B1 (fr)
NZ (1)	NZ251384A (fr)
PL (1)	PL180014B1 (fr)
RU (1)	RU2128650C1 (fr)
SG (1)	SG47948A1 (fr)
SK (1)	SK281258B6 (fr)
TW (1)	TW282455B (fr)
UA (1)	UA29437C2 (fr)
WO (1)	WO1993020052A1 (fr)
ZA (1)	ZA932415B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9320273D0 (en) *	1993-04-01	1993-11-17	Fisons Corp	Compound useful in therapy
EP0356035B1 (fr) *	1988-08-12	1996-03-13	Astra Aktiebolag	Arylalkyl-amines et -amides à activité anticonvulsive et neuroprotectrice
ZA942140B (en) *	1993-04-01	1994-10-03	Fisons Corp	Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy
SE9901077D0 (sv) *	1999-03-23	1999-03-23	Astra Ab	Novel use
SE9901237D0 (sv) *	1999-04-06	1999-04-06	Astra Ab	Novel use
SE9901340D0 (sv)	1999-04-15	1999-04-15	Astra Pharma Prod	Novel process
DK1202986T3 (da) *	1999-07-28	2006-02-20	Ortho Mcneil Pharm Inc	Amin- og amidderivater som ligander for neuropeptid Y-Y5-receptoren, der er nyttige ved behandlingen af obesitet og andre lidelser
WO2007017652A2 (fr) *	2005-08-10	2007-02-15	Astrazeneca Ab	Utilisation therapeutique
US8013165B2 (en) *	2008-12-24	2011-09-06	Astrazeneca Ab	Ethanamine compounds and methods of using the same 545
JP2015501652A (ja)	2011-12-14	2015-01-19	アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａＡｋｔｉｅｂｏｌａｇ	Ｇａｂｒ−ａ２診断
ES2894903T3 (es)	2013-11-05	2022-02-16	Astrazeneca Ab	Profármacos antagonistas de NMDA
KR20230026449A (ko) *	2020-06-23	2023-02-24	바이오하벤 테라퓨틱스 리미티드	(1s)-1-페닐-2-피리딘-2-일레탄아민의 국소 제형

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2673588A (en) *	1987-12-11	1989-06-15	Laboratoires Syntex	1,4-dihydropyridine derivatives as neuroprotective compounds
EP0356035B1 (fr) *	1988-08-12	1996-03-13	Astra Aktiebolag	Arylalkyl-amines et -amides à activité anticonvulsive et neuroprotectrice

1993
- 1993-04-01 KR KR1019940703465A patent/KR100259567B1/ko not_active Expired - Lifetime
- 1993-04-01 JP JP05517251A patent/JP3120810B2/ja not_active Expired - Lifetime
- 1993-04-01 AT AT93907975T patent/ATE163925T1/de active
- 1993-04-01 DE DE69317411T patent/DE69317411T2/de not_active Expired - Lifetime
- 1993-04-01 DK DK93907975T patent/DK0633879T3/da active
- 1993-04-01 ES ES93907975T patent/ES2115055T3/es not_active Expired - Lifetime
- 1993-04-01 RU RU94042465A patent/RU2128650C1/ru active
- 1993-04-01 EP EP93907975A patent/EP0633879B1/fr not_active Expired - Lifetime
- 1993-04-01 SG SG1996005610A patent/SG47948A1/en unknown
- 1993-04-01 AU AU38976/93A patent/AU3897693A/en not_active Abandoned
- 1993-04-01 PL PL93305404A patent/PL180014B1/pl unknown
- 1993-04-01 NZ NZ251384A patent/NZ251384A/en not_active IP Right Cessation
- 1993-04-01 CZ CZ19942409A patent/CZ288519B6/cs not_active IP Right Cessation
- 1993-04-01 CA CA002133427A patent/CA2133427C/fr not_active Expired - Lifetime
- 1993-04-01 UA UA94095853A patent/UA29437C2/uk unknown
- 1993-04-01 SK SK1177-94A patent/SK281258B6/sk not_active IP Right Cessation
- 1993-04-01 WO PCT/GB1993/000689 patent/WO1993020052A1/fr not_active Ceased
- 1993-04-02 MA MA23157A patent/MA22866A1/fr unknown
- 1993-04-02 ZA ZA932415A patent/ZA932415B/xx unknown
- 1993-04-02 MY MYPI93000602A patent/MY110149A/en unknown
- 1993-04-02 MX MX9301935A patent/MX9301935A/es unknown
- 1993-04-02 IL IL105276A patent/IL105276A/xx not_active IP Right Cessation
- 1993-04-03 DZ DZ930038A patent/DZ1677A1/fr active
- 1993-04-03 CN CN93104534A patent/CN1044367C/zh not_active Expired - Lifetime
- 1993-04-30 TW TW082103364A patent/TW282455B/zh not_active IP Right Cessation
1994
- 1994-09-30 FI FI944546A patent/FI105025B/fi not_active IP Right Cessation
- 1994-09-30 NO NO943645A patent/NO302170B1/no not_active IP Right Cessation
1995
- 1995-06-13 HU HU95P/P00192P patent/HU211529A9/hu unknown
1996
- 1996-12-18 AU AU75456/96A patent/AU705419B2/en not_active Expired
2000
- 2000-05-30 JP JP2000159319A patent/JP2000319259A/ja active Pending

Also Published As

Publication number	Publication date
AU3897693A (en)	1993-11-08
CA2133427A1 (fr)	1993-10-14
KR100259567B1 (ko)	2000-07-01
SK281258B6 (sk)	2001-01-18
DE69317411D1 (de)	1998-04-16
CZ240994A3 (en)	1995-12-13
DE69317411T2 (de)	1998-07-30
RU2128650C1 (ru)	1999-04-10
TW282455B (fr)	1996-08-01
AU705419B2 (en)	1999-05-20
MY110149A (en)	1998-02-28
AU7545696A (en)	1997-02-13
DZ1677A1 (fr)	2002-02-17
EP0633879A1 (fr)	1995-01-18
UA29437C2 (uk)	2000-11-15
NO943645D0 (no)	1994-09-30
ES2115055T3 (es)	1998-06-16
CZ288519B6 (cs)	2001-07-11
SG47948A1 (en)	1998-04-17
ZA932415B (en)	1993-10-22
CN1044367C (zh)	1999-07-28
ATE163925T1 (de)	1998-03-15
NZ251384A (en)	1996-10-28
RU94042465A (ru)	1996-07-20
FI105025B (fi)	2000-05-31
NO302170B1 (no)	1998-02-02
HU211529A9 (en)	1995-11-28
IL105276A0 (en)	1993-08-18
WO1993020052A1 (fr)	1993-10-14
NO943645L (no)	1994-11-16
CN1081669A (zh)	1994-02-09
JP2000319259A (ja)	2000-11-21
PL180014B1 (pl)	2000-11-30
EP0633879B1 (fr)	1998-03-11
MX9301935A (es)	1994-08-31
SK117794A3 (en)	1995-05-10
CA2133427C (fr)	2003-06-10
FI944546A0 (fi)	1994-09-30
HK1009331A1 (en)	1999-05-28
DK0633879T3 (da)	1998-09-28
JP3120810B2 (ja)	2000-12-25
FI944546L (fi)	1994-09-30
JPH07505385A (ja)	1995-06-15
IL105276A (en)	1997-06-10

Publication	Publication Date	Title
EG20218A (en)	1997-11-30	Process for preparing of substituted 3 aminoquinuclidines
EP0668750A4 (fr)	1996-04-10	Vis pediculaire et appareillage de correction de la colonne par l'approche posterieure.
MA22626A1 (fr)	1993-04-01	Procede de preparation d'acides imidazolyl-alcenoiques .
FR2690855B1 (fr)	1995-12-08	Adsorbants pour l'elimination de hcl et procede pour leur production et leur utilisation.
BG101118A (en)	1998-04-30	Therapeutical compounds
FR2740132B1 (fr)	1997-12-19	Procede pour la preparation de 1,1,1,3,3-pentafluoropropane
MA22866A1 (fr)	1993-12-31	Procede pour la preparation des composes pour le traitement des troubles neuro-degeneratifs .
EP0673384A4 (fr)	1996-10-09	Polypeptides utiles pour traiter des troubles inflammatoires.
FR2705966B1 (fr)	1995-08-25	Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
MA23134A1 (fr)	1994-10-01	Procede pour la preparation d'aryl-piperidine carbinols .
CA2217513A1 (fr)	1996-10-10	Agents pharmaceutiques pour le traitement de la maladie d'alzheimer
MA23663A1 (fr)	1996-04-01	Procede de preparation de formulations pharmaceutiques
MA22278A1 (fr)	1992-04-01	Procede pour le traitement de troubles respiratoires
FR2700956B1 (fr)	1995-12-01	Composition cosmetique et pharmaceutique et procede pour sa preparation.
FR2733227B1 (fr)	1997-07-04	Procede pour la preparation de 1,1-difluoroethane
MA23081A1 (fr)	1994-10-01	Procede de preparation de derives d'indolone
FR2677354B1 (fr)	1993-09-03	Procede pour la preparation d'esters d'acides racemisables.
MA23953A1 (fr)	1997-04-01	Procede nouveau pour formuler des formes posologiques solides, et formes posologiques ainsi produites
IL99236A0 (en)	1992-07-15	Pharmaceutical composition for the topical treatment of psoriasis
EP0643724A4 (fr)	1995-05-10	Procede d'elaboration de 3-carbonylandrostadiene 17-carboxamides.
FR2703286B1 (fr)	1995-06-30	Procede d'usinage des chants de dalles de pierre et appareil le mettant en oeuvre.
FR2673635B1 (fr)	1994-09-09	Procede pour la preparation d'une composition aerosol.
FR2736635B1 (fr)	1997-08-14	Procede de preparation d'alpha,omega-bromochloroalcanes
FR2696171B1 (fr)	1996-10-25	Procede de preparation du divinylbenzene.
FR2676583B1 (fr)	1995-02-03	Procede pour la desorption d'iode de fission.